Literature DB >> 16264276

Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells.

Hye Won Lim1, Suntaek Hong, Wook Jin, Seunghwan Lim, Su Jung Kim, Hyun Jung Kang, Eun Hee Park, Kisup Ahn, Chang Jin Lim.   

Abstract

Reactive oxygen species (ROS) are involved in a diversity of important phenomena in the process of tumor development. To investigate the alterations of oxidative stress and their related systems in tumor progression, a variety of components in the antioxidative stress defense system were examined in prostate cancer cell lines, PC3 and LNCaP. Cell surface molecules involved in metastasis were expressed highly in PC3 cells compared with LNCaP cells, and strong invasion ability was shown in PC3 cells only. ROS level in LNCaP cells was twice higher than that in PC3 cells, although nitric oxide (NO) level was similar between the two cell lines. The content of GSH increased up to about 2-fold in PC3 compared with LNCaP. Activities of glutathione reductase, thioredoxin reductase, and glutathione S-transferase except catalase are significantly higher in PC3 cells than in LNCaP cells. Furthermore, oxidative stress-inducing agents caused down-regulation of GSH and glutathione S-transferase much more significantly in LNCaP cells than in PC3 cells. These results imply that malignant tumor cells may maintain low ROS content by preserving relatively high anti-oxidative capacity, even in the presence of stressful agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16264276     DOI: 10.1038/emm.2005.62

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  11 in total

1.  A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.

Authors:  Benelita T Elie; Yuriy Pechenyy; Fathema Uddin; María Contel
Journal:  J Biol Inorg Chem       Date:  2018-03-05       Impact factor: 3.358

2.  Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer.

Authors:  Meltem Ozlen Dillioglugil; Haluk Mekık; Bahar Muezzinoglu; T Alp Ozkan; Cennet Gural Demir; Ozdal Dillioglugil
Journal:  Int Urol Nephrol       Date:  2012-06-19       Impact factor: 2.370

3.  Nitric oxide synthase gene polymorphisms and prostate cancer risk.

Authors:  Kyoung-Mu Lee; Daehee Kang; Sue Kyung Park; Sonja I Berndt; Douglas Reding; Nilanjan Chatterjee; Stephen Chanock; Wen-Yi Huang; Richard B Hayes
Journal:  Carcinogenesis       Date:  2009-01-23       Impact factor: 4.944

4.  Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase.

Authors:  Mariana Freitas; Inês Baldeiras; Teresa Proença; Vera Alves; Anabela Mota-Pinto; Ana Sarmento-Ribeiro
Journal:  FEBS Open Bio       Date:  2012-05-30       Impact factor: 2.693

5.  Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells.

Authors:  Vijayalakshmi Thamilselvan; Mani Menon; Sivagnanam Thamilselvan
Journal:  Cancer Manag Res       Date:  2012-11-09       Impact factor: 3.989

6.  Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.

Authors:  Wouter Hendrickx; Julie Decock; Francis Mulholland; Yongping Bao; Susan Fairweather-Tait
Journal:  Front Oncol       Date:  2013-09-23       Impact factor: 6.244

7.  Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression.

Authors:  Ilaria Bellezza; Anna Lisa Mierla; Alba Minelli
Journal:  Cancers (Basel)       Date:  2010-04-13       Impact factor: 6.639

8.  Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.

Authors:  Yiu Fung Mui; Jacob Fernández-Gallardo; Benelita T Elie; Ahmed Gubran; Irene Maluenda; Mercedes Sanaú; Oscar Navarro; María Contel
Journal:  Organometallics       Date:  2016-04-15       Impact factor: 3.876

9.  Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo.

Authors:  Jacob Fernández-Gallardo; Benelita T Elie; Tanmoy Sadhukha; Swayam Prabha; Mercedes Sanaú; Susan A Rotenberg; Joe W Ramos; María Contel
Journal:  Chem Sci       Date:  2015-06-23       Impact factor: 9.825

10.  Phytochemical Characterization, Antioxidant and In Vitro Cytotoxic Activity Evaluation of Juniperus oxycedrus Subsp. oxycedrus Needles and Berries.

Authors:  Reda Ben Mrid; Najat Bouchmaa; Youssef Bouargalne; Btissam Ramdan; Khalid Karrouchi; Imad Kabach; Miloud El Karbane; Abderrazak Idir; Abdelmajid Zyad; Mohamed Nhiri
Journal:  Molecules       Date:  2019-01-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.